Lafora disease E3 ubiquitin ligase malin is recruited to the processing bodies and regulates the microRNA-mediated gene silencing process via the decapping enzyme Dcp1a

References

• Renoux AJ, Todd PK. Neurodegeneration the RNA way. Prog Neurobiol 2012; 97:173 - 89; http://dx.doi.org/10.1016/j.pneurobio.2011.10.006; PMID: 22079416
   PubMed Web of Science ®Google Scholar
• Ranum LP, Cooper TA. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006; 29:259 - 77; http://dx.doi.org/10.1146/annurev.neuro.29.051605.113014; PMID: 16776586
   PubMed Web of Science ®Google Scholar
• Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A 1997; 94:7388 - 93; http://dx.doi.org/10.1073/pnas.94.14.7388; PMID: 9207101
   PubMed Web of Science ®Google Scholar
• Tassone F, Hagerman RJ, Garcia-Arocena D, Khandjian EW, Greco CM, Hagerman PJ. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet 2004; 41:e43; http://dx.doi.org/10.1136/jmg.2003.012518; PMID: 15060119
   PubMed Web of Science ®Google Scholar
• Chen IC, Lin HY, Lee GC, Kao SH, Chen CM, Wu YR, et al. Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci. BMC Mol Biol 2009; 10:9; http://dx.doi.org/10.1186/1471-2199-10-9; PMID: 19203395
   PubMed Web of Science ®Google Scholar
• Dahm R, Macchi P. Human pathologies associated with defective RNA transport and localization in the nervous system. Biol Cell 2007; 99:649 - 61; http://dx.doi.org/10.1042/BC20070045; PMID: 17939777
   PubMed Web of Science ®Google Scholar
• Doi H, Mitsui K, Kurosawa M, Machida Y, Kuroiwa Y, Nukina N. Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates. FEBS Lett 2004; 571:171 - 6; http://dx.doi.org/10.1016/j.febslet.2004.06.077; PMID: 15280037
   PubMed Web of Science ®Google Scholar
• Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res 2010; 66:131 - 3; http://dx.doi.org/10.1016/j.neures.2009.10.004; PMID: 19833157
   PubMed Web of Science ®Google Scholar
• Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 2008; 67:1159 - 65; http://dx.doi.org/10.1097/NEN.0b013e31818e8951; PMID: 19018245
   PubMed Web of Science ®Google Scholar
• Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 2007; 114:221 - 9; http://dx.doi.org/10.1007/s00401-007-0261-2; PMID: 17653732
   PubMed Web of Science ®Google Scholar
• Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 2007; 61:435 - 45; http://dx.doi.org/10.1002/ana.21154; PMID: 17469117
   PubMed Web of Science ®Google Scholar
• Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer’s disease and dementia with Lewy bodies. Brain Res 2007; 1184:284 - 94; http://dx.doi.org/10.1016/j.brainres.2007.09.048; PMID: 17963732
   PubMed Web of Science ®Google Scholar
• Lin WL, Dickson DW. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 2008; 116:205 - 13; http://dx.doi.org/10.1007/s00401-008-0408-9; PMID: 18607609
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314:130 - 3; http://dx.doi.org/10.1126/science.1134108; PMID: 17023659
   PubMed Web of Science ®Google Scholar
• Belzil VV, Valdmanis PN, Dion PA, Daoud H, Kabashi E, Noreau A, et al, S2D team. Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology 2009; 73:1176 - 9; http://dx.doi.org/10.1212/WNL.0b013e3181bbfeef; PMID: 19741216
   PubMed Web of Science ®Google Scholar
• Corrado L, Del Bo R, Castellotti B, Ratti A, Cereda C, Penco S, et al. Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet 2010; 47:190 - 4; http://dx.doi.org/10.1136/jmg.2009.071027; PMID: 19861302
   PubMed Web of Science ®Google Scholar
• Kwiatkowski TJ Jr., Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323:1205 - 8; http://dx.doi.org/10.1126/science.1166066; PMID: 19251627
   PubMed Web of Science ®Google Scholar
• Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323:1208 - 11; http://dx.doi.org/10.1126/science.1165942; PMID: 19251628
   PubMed Web of Science ®Google Scholar
• Gal J, Zhang J, Kwinter DM, Zhai J, Jia H, Jia J, et al. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging 2011; 32:2323 - , e27-40; http://dx.doi.org/10.1016/j.neurobiolaging.2010.06.010; PMID: 20674093
   PubMed Web of Science ®Google Scholar
• Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ Jr., et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 2010; 19:4160 - 75; http://dx.doi.org/10.1093/hmg/ddq335; PMID: 20699327
   PubMed Web of Science ®Google Scholar
• Moisse K, Volkening K, Leystra-Lantz C, Welch I, Hill T, Strong MJ. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Brain Res 2009; 1249:202 - 11; http://dx.doi.org/10.1016/j.brainres.2008.10.021; PMID: 19046946
   PubMed Web of Science ®Google Scholar
• Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderweyde T, Citro A, Mehta T, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 2010; 5:e13250; http://dx.doi.org/10.1371/journal.pone.0013250; PMID: 20948999
   PubMed Web of Science ®Google Scholar
• Nonhoff U, Ralser M, Welzel F, Piccini I, Balzereit D, Yaspo ML, et al. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell 2007; 18:1385 - 96; http://dx.doi.org/10.1091/mbc.E06-12-1120; PMID: 17392519
   PubMed Web of Science ®Google Scholar
• Savas JN, Makusky A, Ottosen S, Baillat D, Then F, Krainc D, et al. Huntington’s disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc Natl Acad Sci U S A 2008; 105:10820 - 5; http://dx.doi.org/10.1073/pnas.0800658105; PMID: 18669659
   PubMed Web of Science ®Google Scholar
• Sheth U, Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 2003; 300:805 - 8; http://dx.doi.org/10.1126/science.1082320; PMID: 12730603
   PubMed Web of Science ®Google Scholar
• Cougot N, Babajko S, Séraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 2004; 165:31 - 40; http://dx.doi.org/10.1083/jcb.200309008; PMID: 15067023
   PubMed Web of Science ®Google Scholar
• Eulalio A, Behm-Ansmant I, Izaurralde E. P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 2007; 8:9 - 22; http://dx.doi.org/10.1038/nrm2080; PMID: 17183357
   PubMed Web of Science ®Google Scholar
• Teixeira D, Sheth U, Valencia-Sanchez MA, Brengues M, Parker R. Processing bodies require RNA for assembly and contain nontranslating mRNAs. RNA 2005; 11:371 - 82; http://dx.doi.org/10.1261/rna.7258505; PMID: 15703442
   PubMed Web of Science ®Google Scholar
• Zeitelhofer M, Karra D, Macchi P, Tolino M, Thomas S, Schwarz M, et al. Dynamic interaction between P-bodies and transport ribonucleoprotein particles in dendrites of mature hippocampal neurons. J Neurosci 2008; 28:7555 - 62; http://dx.doi.org/10.1523/JNEUROSCI.0104-08.2008; PMID: 18650333
   PubMed Web of Science ®Google Scholar
• Ganesh S, Puri R, Singh S, Mittal S, Dubey D. Recent advances in the molecular basis of Lafora’s progressive myoclonus epilepsy. J Hum Genet 2006; 51:1 - 8; http://dx.doi.org/10.1007/s10038-005-0321-1; PMID: 16311711
   PubMed Web of Science ®Google Scholar
• Singh S, Ganesh S. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes. Hum Mutat 2009; 30:715 - 23; http://dx.doi.org/10.1002/humu.20954; PMID: 19267391
   PubMed Web of Science ®Google Scholar
• Ramachandran N, Girard JM, Turnbull J, Minassian BA. The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 2009; 50:Suppl 5 29 - 36; http://dx.doi.org/10.1111/j.1528-1167.2009.02117.x; PMID: 19469843
   PubMed Web of Science ®Google Scholar
• Fernández-Sánchez ME, Criado-García O, Heath KE, García-Fojeda B, Medraño-Fernández I, Gomez-Garre P, et al. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum Mol Genet 2003; 12:3161 - 71; http://dx.doi.org/10.1093/hmg/ddg340; PMID: 14532330
   PubMed Web of Science ®Google Scholar
• Vilchez D, Ros S, Cifuentes D, Pujadas L, Vallès J, García-Fojeda B, et al. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 2007; 10:1407 - 13; http://dx.doi.org/10.1038/nn1998; PMID: 17952067
   PubMed Web of Science ®Google Scholar
• Vernia S, Solaz-Fuster MC, Gimeno-Alcañiz JV, Rubio T, García-Haro L, Foretz M, et al. AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex. J Biol Chem 2009; 284:8247 - 55; http://dx.doi.org/10.1074/jbc.M808492200; PMID: 19171932
   PubMed Web of Science ®Google Scholar
• Worby CA, Gentry MS, Dixon JE. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). J Biol Chem 2008; 283:4069 - 76; http://dx.doi.org/10.1074/jbc.M708712200; PMID: 18070875
   PubMed Web of Science ®Google Scholar
• Solaz-Fuster MC, Gimeno-Alcañiz JV, Ros S, Fernandez-Sanchez ME, Garcia-Fojeda B, Criado Garcia O, et al. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Hum Mol Genet 2008; 17:667 - 78; http://dx.doi.org/10.1093/hmg/ddm339; PMID: 18029386
   PubMed Web of Science ®Google Scholar
• Sengupta S, Badhwar I, Upadhyay M, Singh S, Ganesh S. Malin and laforin are essential components of a protein complex that protects cells from thermal stress. J Cell Sci 2011; 124:2277 - 86; http://dx.doi.org/10.1242/jcs.082800; PMID: 21652633
   PubMed Web of Science ®Google Scholar
• Vernia S, Rubio T, Heredia M, Rodríguez de Córdoba S, Sanz P. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin. PLoS One 2009; 4:e5907; http://dx.doi.org/10.1371/journal.pone.0005907; PMID: 19529779
   PubMedGoogle Scholar
• Garyali P, Siwach P, Singh PK, Puri R, Mittal S, Sengupta S, et al. The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system. Hum Mol Genet 2009; 18:688 - 700; http://dx.doi.org/10.1093/hmg/ddn398; PMID: 19036738
   PubMed Web of Science ®Google Scholar
• Mittal S, Dubey D, Yamakawa K, Ganesh S. Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment. Hum Mol Genet 2007; 16:753 - 62; http://dx.doi.org/10.1093/hmg/ddm006; PMID: 17337485
   PubMed Web of Science ®Google Scholar
• Ganesh S, Agarwala KL, Ueda K, Akagi T, Shoda K, Usui T, et al. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum Mol Genet 2000; 9:2251 - 61; http://dx.doi.org/10.1093/oxfordjournals.hmg.a018916; PMID: 11001928
   PubMed Web of Science ®Google Scholar
• Minassian BA, Andrade DM, Ianzano L, Young EJ, Chan E, Ackerley CA, et al. Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase. Ann Neurol 2001; 49:271 - 5; http://dx.doi.org/10.1002/1531-8249(20010201)49:2<271::AID-ANA52>3.0.CO;2-D; PMID: 11220751
   PubMed Web of Science ®Google Scholar
• Singh PK, Singh S, Ganesh S. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters. Mol Cell Biol 2012; 32:652 - 63; http://dx.doi.org/10.1128/MCB.06353-11; PMID: 22124153
   PubMed Web of Science ®Google Scholar
• Eulalio A, Behm-Ansmant I, Schweizer D, Izaurralde E. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol Cell Biol 2007; 27:3970 - 81; http://dx.doi.org/10.1128/MCB.00128-07; PMID: 17403906
   PubMed Web of Science ®Google Scholar
• Blumenthal J, Ginzburg I. Zinc as a translation regulator in neurons: implications for P-body aggregation. J Cell Sci 2008; 121:3253 - 60; http://dx.doi.org/10.1242/jcs.033266; PMID: 18799791
   PubMed Web of Science ®Google Scholar
• Liu J, Rivas FV, Wohlschlegel J, Yates JR 3rd, Parker R, Hannon GJ. A role for the P-body component GW182 in microRNA function. Nat Cell Biol 2005; 7:1261 - 6; http://dx.doi.org/10.1038/ncb1333; PMID: 16284623
   PubMed Web of Science ®Google Scholar
• Eystathioy T, Jakymiw A, Chan EK, Séraphin B, Cougot N, Fritzler MJ. The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA 2003; 9:1171 - 3; http://dx.doi.org/10.1261/rna.5810203; PMID: 13130130
   PubMed Web of Science ®Google Scholar
• Coller J, Parker R. Eukaryotic mRNA decapping. Annu Rev Biochem 2004; 73:861 - 90; http://dx.doi.org/10.1146/annurev.biochem.73.011303.074032; PMID: 15189161
   PubMed Web of Science ®Google Scholar
• Franks TM, Lykke-Andersen J. The control of mRNA decapping and P-body formation. Mol Cell 2008; 32:605 - 15; http://dx.doi.org/10.1016/j.molcel.2008.11.001; PMID: 19061636
   PubMed Web of Science ®Google Scholar
• Lykke-Andersen J. Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol Cell Biol 2002; 22:8114 - 21; http://dx.doi.org/10.1128/MCB.22.23.8114-8121.2002; PMID: 12417715
   PubMed Web of Science ®Google Scholar
• Turnbull J, Wang P, Girard JM, Ruggieri A, Wang TJ, Draginov AG, et al. Glycogen hyperphosphorylation underlies lafora body formation. Ann Neurol 2010; 68:925 - 33; http://dx.doi.org/10.1002/ana.22156; PMID: 21077101
   PubMed Web of Science ®Google Scholar
• Rehwinkel J, Behm-Ansmant I, Gatfield D, Izaurralde E. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 2005; 11:1640 - 7; http://dx.doi.org/10.1261/rna.2191905; PMID: 16177138
   PubMed Web of Science ®Google Scholar
• Fierro-Monti I, Mathews MB. Proteins binding to duplexed RNA: one motif, multiple functions. Trends Biochem Sci 2000; 25:241 - 6; http://dx.doi.org/10.1016/S0968-0004(00)01580-2; PMID: 10782096
   PubMed Web of Science ®Google Scholar
• Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409:363 - 6; http://dx.doi.org/10.1038/35053110; PMID: 11201747
   PubMed Web of Science ®Google Scholar
• Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008; 29:2073 - 7; http://dx.doi.org/10.1093/carcin/bgn187; PMID: 18700235
   PubMed Web of Science ®Google Scholar
• Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 2008; 105:14879 - 84; http://dx.doi.org/10.1073/pnas.0803230105; PMID: 18812516
   PubMed Web of Science ®Google Scholar
• Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005; 7:719 - 23; http://dx.doi.org/10.1038/ncb1274; PMID: 15937477
   PubMed Web of Science ®Google Scholar
• Behm-Ansmant I, Rehwinkel J, Doerks T, Stark A, Bork P, Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev 2006; 20:1885 - 98; http://dx.doi.org/10.1101/gad.1424106; PMID: 16815998
   PubMed Web of Science ®Google Scholar
• Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J, Fritzler MJ, et al. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 2005; 169:871 - 84; http://dx.doi.org/10.1083/jcb.200502088; PMID: 15967811
   PubMed Web of Science ®Google Scholar
• Kedersha N, Anderson P. Mammalian stress granules and processing bodies. Methods Enzymol 2007; 431:61 - 81; http://dx.doi.org/10.1016/S0076-6879(07)31005-7; PMID: 17923231
   PubMed Web of Science ®Google Scholar
• Franks TM, Lykke-Andersen J. The control of mRNA decapping and P-body formation. Mol Cell 2008; 32:605 - 15; http://dx.doi.org/10.1016/j.molcel.2008.11.001; PMID: 19061636
   PubMed Web of Science ®Google Scholar
• Zeng Y, Sankala H, Zhang X, Graves PR. Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem J 2008; 413:429 - 36; http://dx.doi.org/10.1042/BJ20080599; PMID: 18476811
   PubMed Web of Science ®Google Scholar
• Rzeczkowski K, Beuerlein K, Müller H, Dittrich-Breiholz O, Schneider H, Kettner-Buhrow D, et al. c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies. J Cell Biol 2011; 194:581 - 96; http://dx.doi.org/10.1083/jcb.201006089; PMID: 21859862
   PubMed Web of Science ®Google Scholar
• Rybak A, Fuchs H, Hadian K, Smirnova L, Wulczyn EA, Michel G, et al. The let-7 target gene mouse lin-41 is a stem cell specific E3 ubiquitin ligase for the miRNA pathway protein Ago2. Nat Cell Biol 2009; 11:1411 - 20; http://dx.doi.org/10.1038/ncb1987; PMID: 19898466
   PubMed Web of Science ®Google Scholar
• Romá-Mateo C, Moreno D, Vernia S, Rubio T, Bridges TM, Gentry MS, et al. Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level. BMC Evol Biol 2011; 11:225; http://dx.doi.org/10.1186/1471-2148-11-225; PMID: 21798009
   PubMed Web of Science ®Google Scholar
• Schwamborn JC, Berezikov E, Knoblich JA. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 2009; 136:913 - 25; http://dx.doi.org/10.1016/j.cell.2008.12.024; PMID: 19269368
   PubMed Web of Science ®Google Scholar
• Schaefer A, O’Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R, et al. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 2007; 204:1553 - 8; http://dx.doi.org/10.1084/jem.20070823; PMID: 17606634
   PubMed Web of Science ®Google Scholar
• Hébert SS, Papadopoulou AS, Smith P, Galas MC, Planel E, Silahtaroglu AN, et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 2010; 19:3959 - 69; http://dx.doi.org/10.1093/hmg/ddq311; PMID: 20660113
   PubMed Web of Science ®Google Scholar
• Tao J, Wu H, Lin Q, Wei W, Lu XH, Cantle JP, et al. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J Neurosci 2011; 31:8306 - 19; http://dx.doi.org/10.1523/JNEUROSCI.0567-11.2011; PMID: 21632951
   PubMed Web of Science ®Google Scholar
• Cuellar TL, Davis TH, Nelson PT, Loeb GB, Harfe BD, Ullian E, et al. Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc Natl Acad Sci U S A 2008; 105:5614 - 9; http://dx.doi.org/10.1073/pnas.0801689105; PMID: 18385371
   PubMed Web of Science ®Google Scholar
• Puri R, Suzuki T, Yamakawa K, Ganesh S. Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease. J Biol Chem 2009; 284:22657 - 63; http://dx.doi.org/10.1074/jbc.M109.009688; PMID: 19542233
   PubMed Web of Science ®Google Scholar
• Cougot N, Bhattacharyya SN, Tapia-Arancibia L, Bordonné R, Filipowicz W, Bertrand E, et al. Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal activation. J Neurosci 2008; 28:13793 - 804; http://dx.doi.org/10.1523/JNEUROSCI.4155-08.2008; PMID: 19091970
   PubMed Web of Science ®Google Scholar